We were delighted to catch up with Dr. Bart Westerman (VU Medical Center, Amsterdam UMC, Amsterdam, The Netherlands) to discuss his presentation entitled ‘An AI Model Can Help Predict Adverse Events From New Drug Combinations’, which was presented at AACR 2022, 8-13 April 2022.
- Why is it important to better predict the benefit-risk profile of potential cancer treatments, particularly combination therapy? (0:21)
- What methodology did you use to examine whether a machine learning approach can predict adverse drug reactions from drug combinations? (1:46)
- How accurate was the model in determining individual treatment adverse event profiles? (3:40)
- Are there any potential limitations to this approach? (4:45)
- What further work needs to be conducted to validate the use of the machine learning approach for clinical practice? (5:31)
Disclosures: Bart Westerman discloses receiving Dutch Cancer Society grants KWF-4874 and KWF-11038, Brain Tumour Charity Grant 488097 and APCA-PoC-2017; a relationship with Health Holland that includes: funding grants; receiving a public-private partnership fund from Health Holland on a peer-reviewed project where the company Medstone is the private party and contributor to the project.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
Filmed in coverage of the AACR annual meeting 2022.
Share this Video
Related Videos In Policy
Kim Benstead, European Cancer Summit, 2022: Technical advances in cancer training in Europe
Dr Kim Benstead (Gloucestershire NHS Foundation Trust, London, UK) discusses the most recent improvements in cancer training in Europe, including the major shift online due to the COVID-19 pandemic, and the importance of creating simulations and more interactive training. Questions What have been the most important technological advances in cancer training in Europe? (00:26-01:24) How […]
Kim Benstead, European Cancer Summit, 2022: The INTERACT-EUROPE training programme
Dr Kim Benstead (Gloucestershire NHS Foundation Trust, London, UK) discusses the most recent developments to the European Beating Cancer Plan, including the importance of multidisciplinary in cancer workforces, and the need for quality training schemes. As Chair of INTERACT-EUROPE, she shares her hopes for the new, two-phase training programme to optimise cancer care not only […]
Ajay Aggarwal, European Cancer Summit 2022: Ensuring a better future for young cancer professionals
Dr Ajay Aggarwal (Guy’s and St Thomas’ NHS Trust, London, UK) discusses the need to further develop our future cancer workforce and provide young professionals with enough resources for research but also a strong understanding of what it is to deliver quality cancer care. He also expresses four needs for improvement in current health systems; […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!